CAS 1337531-06-2

GSK2593074A

CAS : 1337531-06-2

GSK2593074A

Degré de pureté : ≥98%

Masse moléculaire : 465.57g/mol

Ref: 54-BUP05275

GSK2593074A

CAS : 1337531-06-2

GSK2593074A is a potent inhibitor of the VSMACs, which are proteins that interact with the extracellular matrix and regulate the inflammatory response. GSK2593074A has been shown to inhibit aneurysm formation by inhibiting the expression levels of gelatinase and MMP2, two key enzymes in aneurysm progression. GSK2593074A also inhibits reactive oxygen species production by muscle cells and has a diameter of 2.5 nm.

Formule : C₂₇H₂₃N₅OS

Degré de pureté : Min. 95%

Masse moléculaire : 465.57 g/mol

Ref: 3D-MDC53106

GSK2593074A

CAS : 1337531-06-2

GSK2593074A (GSK'074) is a programmed necrosis inhibitor that displays inhibitory effects on RIP1 and RIP3.

Formule : C₂₇H₂₃N₅OS

Degré de pureté : 99.99%

Couleur et forme : Solid

Masse moléculaire : 465.57

Ref: TM-T11484